You can buy or sell SLN and other stocks, options, and ETFs commission-free!
Silence Therapeutics Plc engages in the discovery, delivery and development of ribonucleic acid (RNA) therapeutics. It develops medicines by harnessing the body's natural mechanism of RNA interference within its cells. Read More Its proprietary technology can selectively inhibit any gene in the genome, specifically silencing the production of disease-causing proteins. The company was founded on November 18, 1994 and is headquartered in London, the United Kingdom. The listed name for SLN is Silence Therapeutics Plc American Depository Share.
London, Greater London
52 Week High
52 Week Low